who invented glp 1 drugs How Lotte Bjerre Knudsen helped kick off the Age of Wegovy History of GLP-1 Medications -

The rationale behind the formulation addresses three specific challenges that patients encounter during GLP-1 therapy: the appetite suppression and metabolic benefits of semaglutide, the muscle-preserving properties of glycine during rapid weight loss, and the nausea-reducing potential of B12 conjugation with GLP-1 receptor agonists

Doses for type 2 diabetes can vary from 2.5 mg weekly up to 15 mg, although high doses are generally uncommon

He is an editorial board member for Oral Health, an Assistant Professor at the University of Torontos Faculty of Dentistry and past president of the Canadian Academy of Dental Anesthesia.